The Use of Doxepin in the Treatment of Symptoms of Anxiety Neurosis and Accompanying Depression: A Collaborative Controlled Study
Abstract
Fifty-two outpatients with the main target symptom of anxiety with accompanying depression were randomly assigned to receive either doxepin or placebo in a double-blind study for four weeks. The doxepin group improved significantly on global ratings at one week and at four weeks. It was found that at one week patients were significantly improved on symptoms of anxiety, while at four weeks significant improvement occurred in depressive symptomatology.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
